Cosmo Pharmaceuticals N.V. (SWX:COPN)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	885	1,022	818	1,003	1,105	1,229
Market Cap Growth	-19.02%	24.91%	-18.39%	-9.22%	-10.15%	9.61%
Enterprise Value	775	902	780	962	1,066	1,154
Last Close Price	55.50	61.49	47.80	56.28	59.21	76.72
PE Ratio	16.20	8.18	-	58.91	49.16	-
Forward PE	27.04	7.78	28.23	35.51	63.09	-
PS Ratio	5.20	4.08	9.48	9.94	16.37	18.64
PB Ratio	2.03	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	8.84	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	13.98	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	12.89	6.71	38.72	30.54	84.48	87.48
PEG Ratio	-	1.65	1.65	1.65	1.65	1.65
EV/Sales Ratio	4.55	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	10.23	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	12.08	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	12.25	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.01	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.03	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.04	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.29	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.64	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.59	3.39	3.22	1.45	11.77	11.06
Current Ratio	3.84	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	12.34%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	6.88%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	8.80%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	12.20%	24.90%	-	5.00%	1.40%	0.30%
Earnings Yield	6.33%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	7.15%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	3.48%	3.13%	3.90%	1.84%	1.66%	-
Payout Ratio	94.36%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.65%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	1.80%	1.19%	5.85%	4.68%	-15.15%	1.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.